Tweet by Dr. John Cush

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com4,197 pts from the UK Biobank met fibromyalgia criteria, yet 72.6% had NOT received a diagnosis. Non-Dx assoc w/ male, older age, milder sxs or other pain Dx (OA, CRPS, CFS), lower polysymptomatic distress scores,…

Dr. Jack Cush reviews this weeks news from RheumNow.com -- including placebo trumps controversial therapies, the dynamics of disease activity, fuze the big toe, and patients don’t appreciate being told “its all in your head”!

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.Upadacitinib is now approved in European Union to treat active polyarticular juvenile idiopathic arthritis (pJIA) ages > 2yrs for those not responding to 1+ DMARDs. In the USA, UPA is approved for pJIA &…